AptarGroup(ATR) - 2021 Q4 - Earnings Call Presentation

Financial Performance - Q4 2021 - Reported sales growth was +9%[10], with core sales growth of +10%[10] - The Food + Beverage segment experienced double-digit core sales growth, with approximately 60% of the growth attributed to price adjustments[25] - Adjusted EPS and EBITDA were impacted by restructuring initiatives, net unrealized investment loss, and transaction costs related to acquisitions[31] Financial Performance - Full Year 2021 - The company achieved record annual sales, driven by top-line growth across each segment[38] - Core sales growth was 7%, supported by broad-based demand and price adjustments[38] - Reported EPS increased by 12% from FY 2020 to FY 2021[37] Segment Performance - The Pharma segment experienced solid growth in Q4, driven by demand for solutions for vaccines, injected medications, and Active Materials, with a ~50% increase in Active Materials sales due to Activ-Film™ technology[12] - The Beauty + Home segment's growth was primarily driven by price initiatives and increased demand for dispensing systems for fragrance, skincare, and hair care products[25] Strategic Initiatives and Investments - The company is expanding capacity for elastomeric components in France and the U S, with a $55 million investment (net of government grants)[54] - A new facility in Suzhou, China is being built with a $31 million investment to optimize the company's footprint[54]